{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/PEPG/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T08:33:42.337Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":4605,"canonical_name":"PepGen Inc.","cik":"0001835597","uei":null,"lei":null,"duns":null,"ticker":"PEPG"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":9,"clinical":1},"count":10,"timeline":[{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — PepGen Inc. — 2026-08-06","url_slug":"/sec/cik-0001835597/10-q/0001193125-26-336754","accession_number":"0001193125-26-336754","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — PepGen Inc. — 2026-08-06","url_slug":"/sec/cik-0001835597/8-k/0001193125-26-336767","accession_number":"0001193125-26-336767","importance":35},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — PepGen Inc. — 2026-06-22","url_slug":"/sec/cik-0001835597/8-k/0001193125-26-277579","accession_number":"0001193125-26-277579","importance":35},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — PepGen Inc. — 2026-06-22","url_slug":"/sec/cik-0001835597/4/0001835597-26-000034","accession_number":"0001835597-26-000034","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"8-K","title":"8-K — PepGen Inc. — 2026-05-21","url_slug":"/sec/cik-0001835597/8-k/0001193125-26-233403","accession_number":"0001193125-26-233403","importance":35},{"ts":"2026-05-19","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — PepGen Inc. — 2026-05-19","url_slug":"/sec/cik-0001835597/corresp/0001193125-26-230279","accession_number":"0001193125-26-230279","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"S-3","title":"S-3 — PepGen Inc. — 2026-05-18","url_slug":"/sec/cik-0001835597/s-3/0001193125-26-228960","accession_number":"0001193125-26-228960","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — PepGen Inc. — 2026-05-12","url_slug":"/sec/cik-0001835597/10-q/0001193125-26-219375","accession_number":"0001193125-26-219375","importance":45},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — PepGen Inc. — 2026-05-12","url_slug":"/sec/cik-0001835597/8-k/0001193125-26-219424","accession_number":"0001193125-26-219424","importance":35},{"ts":"2026-04-28","kind":"clinical.trial","reporter":"PepGen Inc","title":"A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1","security_title":"PHASE2","status":"RECRUITING","accession_number":"NCT06667453","excerpt":"[\"Myotonic Dystrophy 1\"]","importance":45}]}